349 related articles for article (PubMed ID: 32370916)
1. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
Lwin TM; Hernot S; Hollandsworth H; Amirfakhri S; Filemoni F; Debie P; Hoffman RM; Bouvet M
Surgery; 2020 Jul; 168(1):85-91. PubMed ID: 32370916
[TBL] [Abstract][Full Text] [Related]
2. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer.
Lwin TM; Turner MA; Nishino H; Amirfakhri S; Hernot S; Hoffman RM; Bouvet M
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625638
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
[TBL] [Abstract][Full Text] [Related]
6. Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study.
van Manen L; de Muynck LDAN; Baart VM; Bhairosingh S; Debie P; Vahrmeijer AL; Hernot S; Mieog JSD
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189366
[TBL] [Abstract][Full Text] [Related]
7. Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer.
Maawy AA; Hiroshima Y; Zhang Y; Heim R; Makings L; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
PLoS One; 2015; 10(3):e0121989. PubMed ID: 25799218
[TBL] [Abstract][Full Text] [Related]
8. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
[TBL] [Abstract][Full Text] [Related]
9. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.
Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S
Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.
van Driel PB; van der Vorst JR; Verbeek FP; Oliveira S; Snoeks TJ; Keereweer S; Chan B; Boonstra MC; Frangioni JV; van Bergen en Henegouwen PM; Vahrmeijer AL; Lowik CW
Int J Cancer; 2014 Jun; 134(11):2663-73. PubMed ID: 24222574
[TBL] [Abstract][Full Text] [Related]
11. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
[TBL] [Abstract][Full Text] [Related]
12. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
[TBL] [Abstract][Full Text] [Related]
13. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
[TBL] [Abstract][Full Text] [Related]
15. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
[TBL] [Abstract][Full Text] [Related]
16. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
Cox KE; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Ghosh P; Obonyo M; Murakami T; Hoffman RM; Yazaki PJ; Bouvet M
J Surg Res; 2024 Jan; 293():701-708. PubMed ID: 37839102
[TBL] [Abstract][Full Text] [Related]
17. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
18. An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models.
Metildi CA; Kaushal S; Lee C; Hardamon CR; Snyder CS; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
J Am Coll Surg; 2012 Jun; 214(6):997-1007.e2. PubMed ID: 22542065
[TBL] [Abstract][Full Text] [Related]
19. Toward Curative Fluorescence-Guided Surgery of Pancreatic Cancer.
Bouvet M; Hoffman RM
Hepatogastroenterology; 2015 May; 62(139):715-22. PubMed ID: 26897960
[TBL] [Abstract][Full Text] [Related]
20. Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models.
Park JY; Lee JY; Zhang Y; Hoffman RM; Bouvet M
Oncotarget; 2016 Apr; 7(14):18262-8. PubMed ID: 26919100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
